Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2019 |
polyps
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Anatomical Abnormality
|
390
|
18
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2019 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2001 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Brachial Neuralgia
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cervico-Brachial Neuralgia
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
5
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
138
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Peripheral Nervous System Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
549
|
69
|
0.110 |
None |
1.000 |
1 |
|
2010 |
2010 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Tonometry
|
phenotype |
|
Diagnostic Procedure
|
206
|
573
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Transferrin saturation measurement
|
phenotype |
|
Laboratory Procedure
|
26
|
36
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Serum iron measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
25
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Respiratory distress
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
259
|
16
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
precancerous lesions
|
phenotype |
|
Neoplastic Process
|
270
|
19
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neuropathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
484
|
110
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.010 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Diabetic gastroenteropathy
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperplastic Polyp
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
204
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |